NASDAQ : OM
Outset Medical, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 4.19 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 78.76M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 75.75M |
| Enterprise Value | 33.01M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 18.80M |
| Shares Outstanding | 18.80M |
| Shares Change (YoY) | +129.26% |
| Shares Change (QoQ) | +1.34% |
| Owned by Insiders (%) | 2.70% |
| Owned by Institutions (%) | 54.97% |
| Float | 14.53M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.64 |
| Forward PS | 0.58 |
| PB Ratio | 0.79 |
| P/TBV Ratio | 0.79 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.28 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 5.19 |
| Quick Ratio | 4.02 |
| Debt / Equity | 1.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.81 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -59.17% |
| Return on Assets (ROA) | -15.54% |
| Return on Invested Capital (ROIC) | -18.18% |
| Return on Capital Employed (ROCE) | -33.27% |
| Weighted Average Cost of Capital (WACC) | 12.24% |
| Revenue Per Employee | $380,010 |
| Profits Per Employee | -$239,648 |
| Employee Count | 310 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 1.38 |
Taxes
| Measure | Value |
|---|
| Income Tax | 936,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.92 |
| 52-Week Price Change | -70.10% |
| 50-Day Moving Average | 3.73 |
| 200-Day Moving Average | 4.15 |
| Relative Strength Index (RSI) | 51.79 |
| Average Volume (20 Days) | 117,328 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 932,559 |
| Short Previous Month | 792,696 |
| Short % of Shares Out | 4.96% |
| Short % of Float | 6.42% |
| Short Ratio (days to cover) | 4.78 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 117.80M |
| Gross Profit | 49.20M |
| Operating Income | -66.05M |
| Pretax Income | -73.36M |
| Net Income | -74.29M |
| EBITDA | -62.73M |
| EBIT | -66.05M |
| Loss Per Share | -$4.07 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 147.19M |
| Total Debt | 104.45M |
| Net Cash | 42.75M |
| Net Cash Per Share | $2.27 |
| Equity (Book Value) | 96.34M |
| Book Value Per Share | 5.13 |
| Working Capital | 183.96M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -38.32M |
| Capital Expenditures | -559,000 |
| Depreciation & Amortization | 3.31M |
| Net Borrowing | -93,000 |
| Free Cash Flow | -38.88M |
| FCF Per Share | -$2.07 |
Margins
| Measure | Value |
|---|
| Gross Margin | 41.76% |
| Operating Margin | -56.06% |
| Pretax Margin | -62.27% |
| Profit Margin | -63.06% |
| EBITDA Margin | -53.25% |
| EBIT Margin | -56.06% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -129.26% |
| Shareholder Yield | n/a |
| Earnings Yield | -101.02% |
| FCF Yield | -51.32% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $7.67 |
| Price Target Difference | 90.25% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 8.51% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Mar 20, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -5.87 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |